[{"_id":"5641e8f4fd1ef1594b89c6af","決算期":"2015年5月期","証券コード":"3349","会社名":"(株)コスモス薬品【3349】","会計方式":"日本方式","決算発表日":"2015年7月13日","決算月数":"12か月","売上高":"408,466百万円","営業利益":"17,080百万円","経常利益":"19,028百万円","当期利益":"11,694百万円","EPS（一株当たり利益）":"590.63円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"3,285.70円","総資産":"168,918百万円","自己資本":"65,055百万円","資本金":"4,178百万円","有利子負債":"12,192百万円","自己資本比率":"38.5%","ROA（総資産利益率）":"7.51%","ROE（自己資本利益率）":"19.58%","総資産経常利益率":"12.21%","日付":"2015-11-10T12:55:42.708Z"},{"_id":"5641e8f4fd1ef1594b89c6b0","決算期":"2014年5月期","証券コード":"3349","会社名":"(株)コスモス薬品【3349】","会計方式":"日本方式","決算発表日":"2014年7月11日","決算月数":"12か月","売上高":"371,825百万円","営業利益":"16,707百万円","経常利益":"18,193百万円","当期利益":"10,600百万円","EPS（一株当たり利益）":"535.41円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,747.50円","総資産":"142,700百万円","自己資本":"54,399百万円","資本金":"4,178百万円","有利子負債":"2,708百万円","自己資本比率":"38.1%","ROA（総資産利益率）":"8.21%","ROE（自己資本利益率）":"21.34%","総資産経常利益率":"14.09%","日付":"2015-11-10T12:55:42.708Z"},{"_id":"5641e8f4fd1ef1594b89c6b1","決算期":"2013年5月期","証券コード":"3349","会社名":"(株)コスモス薬品【3349】","会計方式":"日本方式","決算発表日":"2013年7月12日","決算月数":"12か月","売上高":"329,313百万円","営業利益":"15,529百万円","経常利益":"16,787百万円","当期利益":"9,396百万円","EPS（一株当たり利益）":"474.58円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"2,270.24円","総資産":"115,544百万円","自己資本":"44,950百万円","資本金":"4,178百万円","有利子負債":"1,195百万円","自己資本比率":"38.9%","ROA（総資産利益率）":"8.74%","ROE（自己資本利益率）":"23.11%","総資産経常利益率":"15.61%","日付":"2015-11-10T12:55:42.708Z"}]